Key Drug Launches To Plan For In 2019

 
• By John Davis

Around three dozen key late-stage products could reach their first markets in 2019, according to a recent report from Informa Pharma's Biomedtracker. Company execs may need to plan for the disruptive potential of this group of new medicines on established markets and standards of care.

Rocket
A good launch is important if products are to succeed in the marketplace • Source: Shutterstock

More from New Products

More from Scrip